Authors
The complex (6,13-bis(ethoxycarbonyl)-5,14-dimethyl-1,4,8,11-tetraazacyclotetradeca-4,6,12,14-tetraenato(2−))iron(III) iodide, 3 (chemical formula C 18 H 26 O 4 N 4 FeI·0.5 C 7 H 8 ), has been characterized by X-ray crystallography ( a = 16.063(3) Å, b = 15.895(3) Å, c = 19.703(4) Å, β = 107.11(3)°; monocline; I 2/ a; Z = 8), EPR and Mössbauer spectroscopy, and temperature-dependent magnetic susceptibility as well as by MO calculations. The pentacoordinated iron atom is 0.34 Å outside of the [N 4 ] plane. The equatorial Fe−N distances (1.92 Å for the N's in neighborhood of the methylated C-atoms and 1.88 Å for the others) are not significantly different from those found in octahedral low-spin iron(III) complexes with the same macrocyclic [N 4 2- ] ligand. The magnetic moment ( μ eff = 4.19 μ B up to 20 K; ϑ = −7.37 K), the EPR measurements ( g y eff = 5.38, g x eff = 2.70, and g z eff = 1.74), and the Mössbauer data ( δ = 0.18 mm/s, Δ E Q = 3.56 mm/s, T = 120 K) indicate a pure intermediate-spin state of S = 3 / 2 . The MO calculations yield a complete picture of bonding modes, intramolecular interactions, and the electronic structure around the iron center, as indicated by the correct determination of the ground state and by the agreement between the measured and calculated quadrupole splitting.
No takes yet. Share an insight, caveat, or question.
Keutel et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: